LMR Partners’s AEON Biopharma Inc AEON.WS Stock Holding History

LMR Partners’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-249,999	Closed	-$362K	–	1395
2024 Q1	$362K	Hold	249,999	–	–	﹤0.01%	802
2023 Q4	$25K	Hold	249,999	–	–	﹤0.01%	826
2023 Q3	$37.5K	Buy	249,999 +49,999	+25%	+$7.09K	﹤0.01%	743
2023 Q2	$18K	Hold	200,000	–	–	﹤0.01%	734
2023 Q1	$2.03M	Hold	200,000	–	–	0.03%	438
2022 Q4	$2.01M	Hold	200,000	–	–	0.04%	531
2022 Q3	$1.97M	Hold	200,000	–	–	0.04%	552
2022 Q2	$1.96M	Hold	200,000	–	–	0.03%	553
2022 Q1	$1.96M	Hold	200,000	–	–	0.02%	589
2021 Q4	$1.94M	Hold	200,000	–	–	0.02%	502
2021 Q3	$1.95M	Hold	200,000	–	–	0.02%	472
2021 Q2	$200K	Buy	+200,000	New	+$152K	﹤0.01%	781

LMR Partners's AEON.WS Position: Q2 2024 in Review

LMR Partners sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 249,999 shares — an estimated $362K sold.

LMR Partners first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $2.03M in Q1 2023. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

LMR Partners reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
LMR Partners sold 249,999 AEON Biopharma Inc shares in Q2 2024, an estimated $362K.
LMR Partners first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
LMR Partners's AEON Biopharma Inc position peaked at $2.03M in Q1 2023.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.